|
Re: Behold
|
3
|
Mannkind
|
Mar 18, 2013 04:13PM
|
|
Re: Behold
|
|
Mannkind
|
Mar 18, 2013 09:52AM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
|
|
Mannkind
|
Mar 18, 2013 05:39AM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
|
1
|
Mannkind
|
Mar 18, 2013 05:28AM
|
|
Re: Question on the Joe Springer article
|
1
|
Mannkind
|
Mar 17, 2013 09:22PM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
|
|
Mannkind
|
Mar 17, 2013 08:20PM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog
|
1
|
Mannkind
|
Mar 17, 2013 07:51PM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i
|
|
Mannkind
|
Mar 17, 2013 07:03PM
|
|
Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i
|
3
|
Mannkind
|
Mar 17, 2013 05:07PM
|
|
Re: Question on the Joe Springer article
|
4
|
Mannkind
|
Mar 14, 2013 08:06PM
|
|
Re: Question on the Joe Springer article
|
4
|
Mannkind
|
Mar 14, 2013 08:57AM
|
|
Re: Why Options are Better Than Warrants
|
|
Mannkind
|
Mar 13, 2013 05:58PM
|
|
Re: Question about warrants and time values
|
|
Mannkind
|
Mar 12, 2013 05:18PM
|
|
Re: Breakout
|
1
|
Mannkind
|
Mar 11, 2013 05:51PM
|
|
Re: 5 Reasons MannKind Could Be The Best Performing Stock Of 2013
|
|
Mannkind
|
Mar 08, 2013 08:57PM
|
|
Re: Rescue question
|
1
|
Mannkind
|
Mar 02, 2013 06:29AM
|
|
Re: Cowen and Company
|
1
|
Mannkind
|
Feb 20, 2013 06:20PM
|
|
Re: Updated Share Price Model
|
2
|
Mannkind
|
Feb 19, 2013 07:53PM
|
|
Re: What's New in ADA's Latest Diabetes Guidelines?
|
2
|
Mannkind
|
Feb 19, 2013 05:08PM
|
|
Re: Updated Share Price Model
|
2
|
Mannkind
|
Feb 17, 2013 12:59PM
|
